Gene · 6391
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carbon dot-based polyplexes with cell penetration peptides for gene transfection. | RSC Adv | 2025 | 41262758 | PubTator, text mining | PubMed |
| Succinate Dehydrogenase Pathogenic Variants Among Older Adults With Head and Neck Paragangliomas. | Laryngoscope Investig Otolaryngol | 2025 | 41234330 | PubTator, text mining | PubMed |
| SIRT5 Facilitates Liver Steatosis Progression via Promoting SDH Desuccinylation During High-Fat Diet Feeding. | Liver Int | 2025 | 41221659 | PubTator, text mining | PubMed |
| Exploring the Glycolytic Mechanisms in "Driver Gene-Negative" Lung Adenocarcinoma (LUAD): A Single-Cell RNA Sequencing Approach to Identify the MIF-HIF-1α Axis. | J Cancer | 2025 | 41210694 | PubTator, text mining | PubMed |
| A Rare Case of Metastatic Carotid Body Paraganglioma: A 7-Year Asymptomatic Period. | Case Rep Oncol Med | 2025 | 41169441 | PubTator, text mining | PubMed |
| Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma. | Cancer Res Commun | 2025 | 41081835 | PubTator, text mining | PubMed |
| Mitochondrial electron transport chain gene-based prognostic model identifies SDHB as a key regulator of low-grade glioma progression and therapeutic target. | Cancer Cell Int | 2025 | 41063254 | PubTator, text mining | PubMed |
| Specification of frequency criteria for secondary findings genes to improve variant classification concordance. | bioRxiv | 2025 | 41000626 | PubTator, text mining | PubMed |
| Succinate dehydrogenase-related pheochromocytoma and paraganglioma (SDHx-PPGL): clinical and genetic insights from an Indian study. | Endocr Connect | 2025 | 40981001 | PubTator, text mining | PubMed |
| Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database. | Eur J Endocrinol | 2025 | 40974092 | PubTator, text mining | PubMed |
| HIF1A regulates follicular atresia through O-GlcNAcylation-mediated VEZF1/ET-1/FOXO1/BAX signaling in porcine granulosa cells. | J Anim Sci Biotechnol | 2025 | 40973947 | PubTator, text mining | PubMed |
| Cross-resistance in Alternaria brassicicola from naturally infested broccoli seeds against two succinate dehydrogenase inhibitor fungicides. | Appl Environ Microbiol | 2025 | 40905662 | PubTator, text mining | PubMed |
| ACO1 OGDH axis drives mitochondrial immune crosstalk in preeclampsia through systems biology enabling dual target therapy. | Sci Rep | 2025 | 40887492 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of α-D-tocopherol derivatives as anticancer agents targeting mitochondrial metabolism. | Eur J Med Chem | 2025 | 40882437 | PubTator, text mining | PubMed |
| LDLR H3K27ac in PBMCs: An Early Warning Biomarker for Hypercholesterolemia Susceptibility in Male Newborns Treated with Prenatal Dexamethasone. | Toxics | 2025 | 40863927 | PubTator, text mining | PubMed |
| Plasma Biomarkers of Mitochondrial Dysfunction in Patients with Myasthenia Gravis. | Med Sci (Basel) | 2025 | 40843740 | PubTator, text mining | PubMed |
| Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma. | RNA Biol | 2025 | 40836845 | PubTator, text mining | PubMed |
| GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells. | Sci Rep | 2025 | 40835655 | PubTator, text mining | PubMed |
| Complex II assembly drives metabolic adaptation to OXPHOS dysfunction. | Sci Adv | 2025 | 40815660 | PubTator, text mining | PubMed |
| miR-1270 suppresses glioblastoma development by transcriptional inhibition of nuclear factor IX. | Mol Biol Rep | 2025 | 40815328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6391/papers?page=4